Irish life sciences company Malin said it has paid €34.5 million for a 65 per cent stake in Altan Pharma.
Altan is a private Irish-headquartered pharmaceutical company which has acquired the GES Group, a privately-held group of Spanish injectable drug companies, for €87.5 million. Altan raised €40 million as part of the funding for the deal.
"Altan is Malin's third Irish operating asset and we look forward to building out the company from its Irish base,"...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team